University of Texas MD Anderson Cancer Center SC-3 — Houston, Texas

University of Texas MD Anderson Cancer Center SC-3 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

University of Texas MD Anderson Cancer Center SC-3 has participated in 1 clinical trials.

Therapeutic areas: c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas MD Anderson Cancer Center SC-3?

University of Texas MD Anderson Cancer Center SC-3 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas MD Anderson Cancer Center SC-3 conducted?

University of Texas MD Anderson Cancer Center SC-3 has 1 clinical trials on record. Their work covers c-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBM.

Is University of Texas MD Anderson Cancer Center SC-3 accredited by Crixeo Health?

University of Texas MD Anderson Cancer Center SC-3 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas MD Anderson Cancer Center SC-3?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.